W. L. Gore & Associates (Gore) has announced that the first U.S. patient has been enrolled in a prospective, non-randomized, multicenter, single-arm study with five-year follow-up (NCT05489588) to evaluate the investigational GORE® VIAFORT Vascular Stent for the treatment of symptomatic iliofemoral venous obstruction.
Esaote North America, Inc. is proud to announce the release of their new veterinary MyLab™X90VET ultrasound system, now available for purchase in North America.
SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake's Nanobody® sonelokimab based on SHL Medical's Molly® autoinjector technology.
Centricity Vision Inc., a global ophthalmic technology company, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new ZEPTOLink™ IOL Positioning System.
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces its PICO Single Use Negative Pressure Wound Therapy Systems have received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes.
Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, announced that results of the Investigation of Novel Surgical Imaging for Tumor Excision (INSITE).
CardieX Limited announced its new arterial health monitor, the CONNEQT Pulse (Pulse), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Pulse is the only vital signs monitor targeted at home, clinician, and clinical trial use that provides measurements of both brachial blood pressure (the pressure at your arm) and central blood pressure (the pressure at your aorta/heart) in addition to multiple other vascular health biomarkers.
EnChroma – creators of glasses for color blindness – and the University of North Carolina at Chapel Hill’s Department of Health Sciences announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient (CVD).
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced the full commercial launch of two access retractor systems to aid surgeons during minimally invasive spine (MIS) procedures.